Repare Therapeutics Financial Overview
Repare Therapeutics's market cap is currently $96.13M. The company's EPS TTM is $0.08; its P/E ratio is -1.29; Repare Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
